STRATA Skin Sciences Inc. (SSKN)
Company Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions.
The company distributes its products internationally through distributors, and domestically directly to physicians.
The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.
STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
| Country | United States |
| IPO Date | Nov 3, 2005 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 106 |
| CEO | Dr. Dolev Rafaeli Ph.D. |
Contact Details
Address: 5 Walnut Grove Drive Horsham, Pennsylvania United States | |
| Website | https://www.strataskinsciences.com |
Stock Details
| Ticker Symbol | SSKN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001051514 |
| CUSIP Number | 86272A206 |
| ISIN Number | US86272A2069 |
| Employer ID | 13-3986004 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dolev Rafaeli Ph.D. | President, Chief Executive Officer & Vice-Chairman |
| Shmuel Gov | Chief Operating Officer |
| Jay Sturm | General Counsel & Corporate Secretary |
| John Gillings | Principal Financial Officer & Principal Accounting Officer |
| Michael R. Stewart | Independent Consultant |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | 10-K | Annual Report |
| Mar 27, 2025 | 8-K | Current Report |
| Mar 20, 2025 | 8-K | Current Report |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 05, 2024 | S-3/A | [Amend] Filing |
| Nov 22, 2024 | S-3 | Filing |
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 14, 2024 | 3 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | 10-Q | Quarterly Report |